Biotest Aktiengesellschaft (BIO) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.114x

Based on the latest financial reports, Biotest Aktiengesellschaft (BIO) has a cash flow conversion efficiency ratio of -0.114x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-58.10 Million ≈ $-67.93 Million USD) by net assets (€509.60 Million ≈ $595.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biotest Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Biotest Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Biotest Aktiengesellschaft debt and liabilities for a breakdown of total debt and financial obligations.

Biotest Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotest Aktiengesellschaft ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	0.062x
Nabors Industries Ltd F:NBI1	0.171x
Daishin Sec KO:003540	-0.415x
Ningbo Donly Co Ltd SHE:002164	0.028x
Triveni Engineering & Industries Limited NSE:TRIVENI	0.012x
Qisda Corp TW:2352	0.051x
Brookline Bancorp Inc NASDAQ:BRKL	0.027x
Beijing SL Pharmaceutical Co Ltd SHE:002038	-0.003x

Annual Cash Flow Conversion Efficiency for Biotest Aktiengesellschaft (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotest Aktiengesellschaft from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Biotest Aktiengesellschaft market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€530.70 Million ≈ $620.44 Million	€60.90 Million ≈ $71.20 Million	0.115x	+2220.40%
2023-12-31	€498.90 Million ≈ $583.27 Million	€-2.70 Million ≈ $-3.16 Million	-0.005x	+95.04%
2022-12-31	€371.10 Million ≈ $433.85 Million	€-40.50 Million ≈ $-47.35 Million	-0.109x	-222.46%
2021-12-31	€380.40 Million ≈ $444.73 Million	€33.90 Million ≈ $39.63 Million	0.089x	+335.65%
2020-12-31	€441.60 Million ≈ $516.28 Million	€-16.70 Million ≈ $-19.52 Million	-0.038x	+46.32%
2019-12-31	€476.90 Million ≈ $557.55 Million	€-33.60 Million ≈ $-39.28 Million	-0.070x	+30.22%
2018-12-31	€495.20 Million ≈ $578.94 Million	€-50.00 Million ≈ $-58.46 Million	-0.101x	-202.38%
2017-12-31	€347.80 Million ≈ $406.61 Million	€34.30 Million ≈ $40.10 Million	0.099x	-46.02%
2016-12-31	€360.70 Million ≈ $421.70 Million	€65.90 Million ≈ $77.04 Million	0.183x	+97.71%
2015-12-31	€412.30 Million ≈ $482.02 Million	€38.10 Million ≈ $44.54 Million	0.092x	+489.25%
2014-12-31	€480.20 Million ≈ $561.40 Million	€-11.40 Million ≈ $-13.33 Million	-0.024x	-51.90%
2013-12-31	€460.70 Million ≈ $538.61 Million	€-7.20 Million ≈ $-8.42 Million	-0.016x	-116.63%
2012-12-31	€369.43 Million ≈ $431.91 Million	€34.73 Million ≈ $40.60 Million	0.094x	-54.92%
2011-12-31	€346.67 Million ≈ $405.29 Million	€72.28 Million ≈ $84.50 Million	0.208x	-17.59%
2010-12-31	€307.61 Million ≈ $359.63 Million	€77.83 Million ≈ $90.99 Million	0.253x	+115.51%
2009-12-31	€269.86 Million ≈ $315.50 Million	€31.68 Million ≈ $37.04 Million	0.117x	-13.75%
2008-12-31	€253.37 Million ≈ $296.22 Million	€34.49 Million ≈ $40.32 Million	0.136x	-5.47%
2007-12-31	€225.76 Million ≈ $263.94 Million	€32.51 Million ≈ $38.01 Million	0.144x	-1.85%
2006-12-31	€179.31 Million ≈ $209.64 Million	€26.31 Million ≈ $30.76 Million	0.147x	-12.46%
2005-12-31	€168.97 Million ≈ $197.55 Million	€28.32 Million ≈ $33.11 Million	0.168x	-28.46%
2004-12-31	€107.97 Million ≈ $126.22 Million	€25.29 Million ≈ $29.57 Million	0.234x	+46.49%
2003-12-31	€103.29 Million ≈ $120.75 Million	€16.52 Million ≈ $19.31 Million	0.160x	+619.93%
2002-12-31	€110.79 Million ≈ $129.53 Million	€2.46 Million ≈ $2.88 Million	0.022x	--

About Biotest Aktiengesellschaft

XETRA:BIO Germany

Market Cap

$976.15 Million

€834.96 Million EUR

Market Cap Rank

#9211 Global

#1150 in Germany

Share Price

€42.20

Change (1 day)

-0.94%

52-Week Range

€42.00 - €43.00

All Time High

€44.10